---
title: "Why Is WORK Medical Technology Stock Falling Friday?"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286592952.md"
description: "WORK Medical (WOK) stock plummeted 49% to $0.66 on Friday as investors took profits after a volatile week. The stock had surged 4,608.33% earlier, driven by a partnership with Shanghai Novabioplus. Despite the initial rally, the stock is now in a long-term downtrend, trading significantly below key moving averages. Current technical indicators suggest a stabilizing momentum, with key resistance at $1.38 and support at 19 cents."
datetime: "2026-05-15T16:07:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286592952.md)
  - [en](https://longbridge.com/en/news/286592952.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286592952.md)
---

# Why Is WORK Medical Technology Stock Falling Friday?

**WORK Medical Technology Group Ltd** (NASDAQ:WOK) shares are retreating sharply Friday morning. The stock dropped over 49% to 66 cents as of Friday. This decline follows a period of extreme volatility.

The Nasdaq is down 1.65% while the S&P 500 has shed 1.18%.

## **Massive Weekly Volatility Cools Off**

The Hangzhou-based medical supplier experienced a historic rally earlier this week. The stock surged 4,608.33% from a Monday low of 24 cents to a peak of $11.30 on Tuesday. Since hitting those highs, the price has trended steadily downward.

## **Traders Exit On Profit-Taking**

Retail momentum traders are now exiting positions. The stock is experiencing a sharp hangover after the rapid ascent. Friday’s move reflects cooling sentiment as investors secure gains from the news-driven spike.

## **The Shanghai Novabioplus Catalyst**

The initial rally stemmed from a deal with **Shanghai Novabioplus Biotechnology Co., Ltd**. This agreement focuses on a Data-Model-Application trinity. Management calls the partnership a “significant milestone” for their digital ecosystem evolution.

## **Focus On Digital BioTokens**

WOK is currently developing a BioToken framework. This system aims to digitize biopharmaceutical research and development outputs. The model mirrors their existing real-world assets (RWA) strategy. Current projects include antibody sequence optimization and enzyme molecule design.

## **WOK Stock: Technical Analysis**

From a trend perspective, WOK is still in a deep longer-term downtrend, with the stock down 99.99% over the past 12 months and trading well below its key moving averages.

At the current level, it’s trading 62.9% below its 20-day SMA ($1.73) and 53.8% below its 50-day SMA ($1.38), which keeps rallies prone to getting sold into.

Momentum is more “stabilizing than strong” right now, with RSI at 47.13—neutral and consistent with choppy, two-way trade rather than a clean rebound.

For general readers, RSI is a quick way to gauge whether a move is getting stretched; readings near the middle typically mean neither buyers nor sellers have clear control.

The moving-average structure also shows why the bigger picture remains heavy: the 20-day SMA is above the 50-day SMA (a short-term bullish crossover), but the 50-day SMA is still below the 200-day SMA, which is a classic bearish long-term setup.

Key turning points reinforce the volatility—RSI hit overbought in May and the stock also logged both a recent swing high and swing low in May, suggesting sharp reversals rather than steady trend.

-   **Key Resistance**: $1.38 — near the 50-day SMA, a common area where downtrends see supply return
-   **Key Support**: 19 cents — the 52-week low zone, a level traders often watch for capitulation risk

**WOK Stock Price Activity:** WORK Medical shares were down 49.23% at $0.66 at the time of publication on Friday, according to Benzinga Pro data.

_Photo via Shutterstock_

### Related Stocks

- [WOK.US](https://longbridge.com/en/quote/WOK.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [.IXIC.US](https://longbridge.com/en/quote/.IXIC.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)

## Related News & Research

- [WORK Medical Collaborates with Novabioplus to Unlock Biological Data Value with AI, Advancing the “BioToken” Assetization Model | WOK Stock News](https://longbridge.com/en/news/285950142.md)
- [embecta Completes Acquisition of Owen Mumford Holdings Limited](https://longbridge.com/en/news/286571686.md)
- [Atara Biotherapeutics Announces First Quarter 2026 Financial Results and Operational Progress | ATRA Stock News](https://longbridge.com/en/news/286148673.md)
- [BUZZ-Dexcom climbs on plans to revamp board panel](https://longbridge.com/en/news/286583878.md)
- [Stryker Buys Amplitude Vascular Systems For Upto $835 Mln To Expand Vascular Treatment Business](https://longbridge.com/en/news/286889480.md)